Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Autoantibodies Stories

2014-03-18 23:02:43

Discounted research study “PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022” elaborated by GlobalData is now available at MarketPublishers.com. According to the report, new product launches are set to fuel SLE and LN treatment markets expansion through to 2022. London, UK (PRWEB) March 18, 2014 The systemic Lupus Erythematosus (SLE) treatment market in the 7 major nations (the US, Germany, France, the UK, Italy, Japan,...

2013-12-03 08:34:10

Benlysta Has Enabled SLE Patients to Decrease Their Steroid Dose Or Stop Taking Steroids Entirely, According to a New Report from BioTrends Research Group EXTON, Pa., Dec. 3, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 80 percent of surveyed rheumatologists agree that a steroid-sparing effect would be an important benefit of a new drug for the treatment of systemic lupus...

2013-11-19 23:20:20

Reportbuyer.com just published a new market research report: EpiCast Report: Systemic Lupus Erythematosus Epidemiology Forecast to 2022. London (PRWEB) November 19, 2013 EpiCast Report: Systemic Lupus Erythematosus Epidemiology Forecast to 2022 Summary Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any organ or organ systems, resulting in a broad spectrum of clinical manifestations ranging from dermatological involvement to...

2013-10-30 08:32:16

Key Drivers of Growth Will Be the Continued Uptake of Benlysta and the Entry of Several Premium-Priced Biologics, According to Findings from Decision Resources BURLINGTON, Mass., Oct. 30, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the systemic lupus erythematosus (SLE) market will grow dramatically over the next decade from approximately $900 million in 2012 to $4 billion in...

2013-08-27 23:23:16

This EpiCast report (http://www.reportsnreports.com/reports/267627-epicast-report-systemic-lupus-erythematosus-epidemiology-forecast-to-2022.html ) says Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any organ or organ systems, resulting in a broad spectrum of clinical manifestations ranging from dermatological involvement to multi-organ failure with episodes of relapses and remissions. Dallas, Texas (PRWEB) August 27, 2013 The...

2013-08-08 08:31:35

Biologic Agents, Including Rituxan and Benlysta, are Reserved for Moderate-to-Severe Cases of SLE, According to a New Report from BioTrends Research Group EXTON, Pa., Aug. 8, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that rheumatologists in the EU5 countries (France, Germany, Italy, Spain, United Kingdom) give Genentech/Biogen Idec's Rituxan and GlaxoSmithKline/Human Genome...

2013-04-25 08:35:38

Although Physicians are Pleased to Have An Additional Treatment Option for SLE, They Wish Benlysta Had a Broader Indication, According to a New Report from BioTrends Research Group EXTON, Pa., April 25, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the top five unmet needs for new SLE therapies are long-term safety, reduction in disease activity/flares, sustained efficacy,...

2010-06-18 02:03:09

A single species of bacteria that lives in the gut is able to trigger a cascade of immune responses that can ultimately result in the development of arthritis. Our gut, like that of most mammals, is filled with thousands of species of bacteria, many of which are helpful and aid in the development of a normal, healthy immune system. Gut-residing bacteria can also play a role in disorders of the immune system, especially autoimmune disorders in which the body attacks its own cells. It turns out...

2010-02-16 08:48:30

Individuals with the sleep disorder narcolepsy suffer with excessive daytime sleepiness and attacks of muscle paralysis triggered by strong emotions (a condition known as cataplexy). It is thought that narcolepsy is an autoimmune disorder "” that is, it is caused by the individual's immune system attacking certain cells in the body "” but this has not yet been proven definitively. However, Mehdi Tafti and colleagues, at the University of Lausanne, Switzerland, have now identified...

2008-01-08 10:38:09

Women who doll up with too much perfume might not know it because they're depressed. That's the conclusion of Dr. Yehuda Shoenfeld, a physician and autoimmune disease researcher at Tel Aviv University in Israel who studies "autoantibodies." This class of chemicals launches attacks against the body's cells, often in patients with autoimmune disease such as lupus. "Our scientific findings suggest that women who are depressed are also losing their sense of smell, and may...